Roth Capital Partners analyst Bill Kirk reiterated a buy rating and a 5 Canadian dollar price target on Canopy Growth, implying a roughly fourfold gain from current levels. Kirk cited record adjusted EBITDA in the recently completed fiscal fourth quarter when excluding one-time expenses, along with improved market share and cost-reduction efforts. However, his own fiscal 2027 estimates project only modest revenue growth of about 5.1% and near-breakeven adjusted EBITDA, making a 4x surge difficult to envision. The average analyst price target stands at $1.22 per share, about 27% above recent trading levels. Investors bullish on U.S. legalization may find stronger fundamentals in already profitable state-licensed U.S. cannabis companies.
Canopy Growth CorpAnalyst reiterated buy rating and price target implying 4x gain, citing record adjusted EBITDA and cost improvements.